<DOC>
	<DOCNO>NCT01983644</DOCNO>
	<brief_summary>Endovascular therapy increasingly used patient moderate-to-severe acute ischemic stroke.This study compare efficacy safety RECO ( novel , self-expanding stent retriever ) Solitaire FR within 8 hour stroke onset cause large vessel occlusion .</brief_summary>
	<brief_title>RECO Flow Restoration Device Versus Solitaire FR With Intention Thrombectomy Study</brief_title>
	<detailed_description>RECO novel , self-expanding stent retriever , design yield rapid flow restoration acute cerebral ischaemia . The propose study multicenter , randomize , prospective , parallel-group , open-label clinical trial blind outcome , test RECO ( novel , self-expanding stent retriever ) , compare Solitaire FR stent retriever .</detailed_description>
	<criteria>1. age ( 1880 year ) 2. acute ischemic stroke 3. within 8 hour symptom onset 4. largevessel confirm CTA/MRA ( eg , internal carotid , middle cerebral M1 and/or M2 segment ) 5 . NIHSS ( ≥8 ≤24 ) 6. patient legally authorise representative provide sign , informed consent . 1 . CT MRI evidence intracranial haemorrhage/tumor 2. major ischaemic infarction ( acute ischaemic change third middle cerebral artery territory ) 3 . NIHSS ( ≥25 ≤7 ) 4. severe sustain hypertension ( systolic blood pressure &gt; 185 mm Hg diastolic blood pressure &gt; 110 mm Hg ) 5. baseline glucose concentration less 2·7 mmol/L high 21.6 mmol/L 6. know haemorrhagic diathesis , coagulation factor deficiency , oral anticoagulant therapy international normalise ratio 1.7 7. treatment heparin within 48 h partial thromboplastin time two time laboratory normal , baseline platelet count less 100×10^9/L 8. history severe allergy ( bad rash ) contrast medium nitinol 9. pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>acute ischemic stroke , endovascular recanalization</keyword>
	<keyword>mechanical thrombectomy</keyword>
</DOC>